PURPOSE: Panelists will discuss the importance of high-validity, real-world evidence and its ever-increasing role in the decision-making process for payers, regulators, and providers.

DESCRIPTION: In an initial 15-minute presentation, each panelist will take 5 minutes to share their institutions’ experience with advanced real-world evidence. In a 25-minute discussion, panel members will respond to questions posed by moderator Dan Riskin, CEO of Verantos and Adjunct Professor of Surgery and Biomedical Informatics Research at Stanford University. Kara Kilpatrick, Director of Observational Research at Amgen, will discuss Amgen’s early results in applying high-validity real-world evidence to asthma. Dr. Arthur Garan, Director of Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease at Harvard’s Beth Israel Deaconess Medical Center, will discuss their engagement in real-world evidence and how it’s influencing care delivery. Finally, Dr. Steve Kymes, Lundbecks’ Director of Health Economics and Outcomes Research, will discuss advanced real-world evidence efforts in migraine and how advanced techniques are implemented at the time of product launch. We invite attendees to converse with the moderator and panelists in a 15-minute open Q+A following this discussion.